As the first earnings cycle of 2025 is ramping up, so are the announcements of new share buyback authorizations. Among these announcements, three big-name U.S. stocks stick out so far, all of which ...
Sanofi (NASDAQ:SNY) reported robust financial results for the fourth quarter of 2024, driven by significant sales growth and a solid increase in earnings per share (EPS). The company's net sales rose ...
Results that may be inaccessible to you are currently showing.